Literature DB >> 8613533

Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy.

J I McMillan1, J W Riordan, W G Couser, A S Pollock, D H Lovett.   

Abstract

The role of the glomerular visceral epithelial cell in the physiologic turnover and pathologic breakdown of the glomerular extracellular matrix has remained largely unexplored. In this study a 98-kD neutral proteinase secreted by cultured rat visceral glomerular epithelial cells was shown to be a calcium, zinc-dependent enzyme secreted in latent form. In addition, the protein was heavily glycosylated and demonstrated proteolytic activity against Type I gelatin, Type IV collagen gelatin, and fibronectin. The similarity in molecular mass and substrate specificities to the 92-kD human matrix metalloproteinase-9 (MMP-9, or gelatinase B) suggested the identity of this activity, which was confirmed by immunoprecipitation and Northern blot analysis. The differences in molecular mass (98 vs. 92 kD) were not due to species-specific differences in glycosylation patterns, since cultured rat peritoneal macrophages secreted MMP-9 as a 92-kD enzyme. Furthermore, transfection of the human MMP-9 cDNA into rat glomerular epithelial cells yielded the 98-kD product. Using a specific monoclonal anti-MMP-9 antibody and in situ reverse transcription (ISRT) analysis of MMP-9 mRNA, the expression of this enzyme was evaluated in vivo. Normal rat glomeruli expressed little immunohistochemical or ISRT staining for MMP-9, while in rats with passive Heymann nephritis there was a major increase in MMP-9 protein and mRNA staining within the visceral epithelial cells. The temporal patterns of MMP-9 expression correlated with the period of proteinuria associated with this model, suggesting that a causal relationship may exist between GEC MMP-9 expression and changes in glomerular capillary permeability.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613533      PMCID: PMC507157          DOI: 10.1172/JCI118502

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  Glomerular epithelial cells secrete a glomerular basement membrane-degrading metalloproteinase.

Authors:  R Johnson; H Yamabe; Y P Chen; C Campbell; K Gordon; P Baker; D Lovett; W G Couser
Journal:  J Am Soc Nephrol       Date:  1992-03       Impact factor: 10.121

2.  Proteolytic enzymes as mediators of glomerular injury.

Authors:  W H Baricos; S V Shah
Journal:  Kidney Int       Date:  1991-08       Impact factor: 10.612

3.  A novel metalloproteinase present in freshly isolated rat glomeruli.

Authors:  Q Le; S Shah; H Nguyen; S Cortez; W Baricos
Journal:  Am J Physiol       Date:  1991-04

Review 4.  Proteinases and glomerular matrix turnover.

Authors:  M Davies; J Martin; G J Thomas; D H Lovett
Journal:  Kidney Int       Date:  1992-03       Impact factor: 10.612

5.  Gelatinase secretion by glomerular epithelial cells.

Authors:  K Watanabe; S Kinoshita; H Nakagawa
Journal:  Nephron       Date:  1990       Impact factor: 2.847

6.  Gelatinase contributes to the degradation of glomerular basement membrane collagen by human neutrophils.

Authors:  M C Vissers; C C Winterbourn
Journal:  Coll Relat Res       Date:  1988-03

7.  Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties.

Authors:  Y Okada; Y Gonoji; K Naka; K Tomita; I Nakanishi; K Iwata; K Yamashita; T Hayakawa
Journal:  J Biol Chem       Date:  1992-10-25       Impact factor: 5.157

8.  Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain.

Authors:  J Floege; R J Johnson; C E Alpers; S Fatemi-Nainie; C A Richardson; K Gordon; W G Couser
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

9.  Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.

Authors:  T Morodomi; Y Ogata; Y Sasaguri; M Morimatsu; H Nagase
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

10.  The human neutrophil serine proteinases, elastase and cathepsin G, can mediate glomerular injury in vivo.

Authors:  R J Johnson; W G Couser; C E Alpers; M Vissers; M Schulze; S J Klebanoff
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

View more
  33 in total

1.  Co-operative interactions between NFAT (nuclear factor of activated T cells) c1 and the zinc finger transcription factors Sp1/Sp3 and Egr-1 regulate MT1-MMP (membrane type 1 matrix metalloproteinase) transcription by glomerular mesangial cells.

Authors:  Maria Alejandra Alfonso-Jaume; Rajeev Mahimkar; David H Lovett
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

Review 2.  Experimental membranous nephropathy redux.

Authors:  Andrey V Cybulsky; Richard J Quigg; David J Salant
Journal:  Am J Physiol Renal Physiol       Date:  2005-10

3.  Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions.

Authors:  Yuri Ozawa; Hiroyuki Kobori; Yuki Suzaki; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2006-06-27

Review 4.  Mechanisms of immune-deposit formation and the mediation of immune renal injury.

Authors:  Masaomi Nangaku; William G Couser
Journal:  Clin Exp Nephrol       Date:  2005-09       Impact factor: 2.801

5.  Activation of gelatinases by fibrin is PA/plasmin system-dependent in human glomerular endothelial cells.

Authors:  Guangyan Cai; Xiangmei Chen; Bo Fu; Yang Lu
Journal:  Mol Cell Biochem       Date:  2005-09       Impact factor: 3.396

6.  Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of matrix metalloproteinases 2 and 1 in the glomeruli of human glomerular diseases: the results of studies using immunofluorescence, in situ hybridization, and immunoelectron microscopy.

Authors:  Makiho Sekiuchi; Akihiko Kudo; Kimimasa Nakabayashi; Masami Kanai-Azuma; Yoshihiro Akimoto; Hayato Kawakami; Akira Yamada
Journal:  Clin Exp Nephrol       Date:  2012-05-22       Impact factor: 2.801

7.  Matrix Metalloproteinase 20 Co-expression With Dentin Sialophosphoprotein in Human and Monkey Kidneys.

Authors:  Kalu U E Ogbureke; Komal Koli; Geetu Saxena
Journal:  J Histochem Cytochem       Date:  2016-10       Impact factor: 2.479

Review 8.  Soluble biglycan as a biomarker of inflammatory renal diseases.

Authors:  Louise Tzung-Harn Hsieh; Madalina-Viviana Nastase; Jinyang Zeng-Brouwers; Renato V Iozzo; Liliana Schaefer
Journal:  Int J Biochem Cell Biol       Date:  2014-08-01       Impact factor: 5.085

9.  Effect of all-trans retinoic acid on renal expressions of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rats with glomerulosclerosis.

Authors:  Yuan-Han Qin; Feng-Ying Lei; Peng Hu; Juan Pei; Zhen-Bo Feng; Yu-Sheng Pang
Journal:  Pediatr Nephrol       Date:  2009-04-09       Impact factor: 3.714

Review 10.  Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men.

Authors:  P Ronco; H Debiec
Journal:  Semin Immunopathol       Date:  2007-09-26       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.